Triple receptor agonist research peptide. Purity >=99%. FOR RESEARCH USE ONLY.
FOR RESEARCH USE ONLY – NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Retatrutide (LY3437943) is a novel triple GIP/GLP-1/Glucagon receptor agonist peptide. Studied extensively in metabolic and receptor pharmacology in-vitro laboratory models.
| Vial Size | 2mg | 5mg | 10mg |
|---|
| Purity | >=99% HPLC |
|---|---|
| Molecular Weight | N/A |
| Storage | Store at -20C away from light |
All products are third-party tested for identity, purity (≥99%), and endotoxin levels per established research standards.
CoA available upon request: support@maxxerbiotech.com
Purity verified by HPLC. Endotoxin analysis performed per standard research protocols.
⚠ FOR RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION.
All products sold by MAXXER BIOTECH RESEARCH are intended strictly for laboratory research, analytical, and in-vitro research purposes only. These products must be handled by qualified research professionals.
Maxxer Biotech Research is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
Statements on this website have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.